•  25
    What Role Does Regulation Play in Responsible Innovation of Nanotechnology in Food and Agriculture? Insights and Framings from U.S. Stakeholders
    with Maude Cuchiara, Khara D. Grieger, and Ashton W. Merck
    Bulletin of Science, Technology and Society 42 (3): 85-103. 2022.
    Historically, market regulation has played an important role in shaping the trajectory of scientific and technological innovation in food and agriculture. However, regulators’ traditional focus on safety and efficacy may be insufficient to address more complex ethical, legal, and social implications of novel products, such as the use of nanotechnology and nanomaterials in food and agriculture. One solution might be to implement the principles of responsible innovation to challenge innovators and…Read more
  •  13
    Formulating best practices for responsible innovation of nano-agrifoods through stakeholder insights and reflection
    with Khara Grieger and Ashton Merck
    Journal of Responsible Technology 10 (C): 100030. 2022.
  •  29
    Responsible Innovation Definitions, Practices, and Motivations from Nanotechnology Researchers in Food and Agriculture
    with Adam E. Kokotovich, Christopher L. Cummings, and Khara Grieger
    NanoEthics 15 (3): 229-243. 2021.
    The growth of responsible innovation scholarship has been mirrored by a proliferation of RI definitions and practices, as well as a recognition of the importance of context for RI. This study investigates how researchers in the field of nanotechnology for food and agriculture define and practice RI, as well as what motivations they see for pursuing RI. We conducted 20 semi-structured interviews with nano-agrifood researchers from industry and academia in the USA, where we asked them to describe …Read more
  •  17
    Deficits of Public Deliberation in U.S. Oversight for Gene Edited Organisms
    Hastings Center Report 51 (S2): 25-33. 2021.
    Environmental releases of gene edited (GEdOs) and gene drive organisms (GDOs) will likely occur under conditions of high uncertainty and in complex socioecological systems. Therefore, public deliberation is especially important to account for diverse interpretations of safety, risks, and benefits; to draw on experiential and public wisdom in areas of proposed release; to ameliorate dangers of technological optimism; and to increase the public legitimacy of decisions. Yet there is a “democratic d…Read more
  •  37
    For the purposes of conservation or suppression of species, gene drive technology has significant potential. Theoretically speaking, with the release of even relatively few animals with gene drive systems in an ecosystem, beneficial or harmful genes could be introduced into the entire wild-type population of that species. Given the profound impact that gene drives could have on species and ecosystems, their use is a highly contentious issue. Communities and groups have differing beliefs about na…Read more
  •  12
    Conflicting Futures: Environmental Regulation of Plant Targeted Genetic Modification
    with Adam Kokotovich
    Bulletin of Science, Technology and Society 34 (3-4): 108-120. 2014.
    Novel targeted genetic modification (TagMo) techniques for plants have the potential to increase the speed and ease of genetic modification and fall outside existing regulatory authority. We conducted 31 interviews with expert-stakeholders to explore the differing visions they have for the future of plant TagMo environmental regulation. To guide our analysis we review the tenets of anticipatory governance in light of future studies literature on emerging technology, focusing on how to contribute…Read more
  •  102
    There is a “revolving door” between federal agencies and the industries regulated by them. Often, at the end of their industry tenure, key industry personnel seek employment in government regulatory entities and vice versa. The flow of workers between the two sectors could bring about good. Industry veterans might have specialized knowledge that could be useful to regulatory bodies and former government employees could help businesses become and remain compliant with regulations. But the “revolv…Read more
  •  18
    Introduction
    with Jordan Paradise, Susan M. Wolf, Gurumurthy Ramachandran, and Efrosini Kokkoli
    Journal of Law, Medicine and Ethics 37 (4): 543-545. 2009.
  •  18
    The Challenge of Developing Oversight Approaches to Nanobiotechnology
    with Jordan Paradise, Susan M. Wolf, Gurumurthy Ramachandran, and Efrosini Kokkoli
    Journal of Law, Medicine and Ethics 37 (4): 543-545. 2009.
  •  46
    Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences
    with Jordan Paradise, Susan M. Wolf, Aliya Kuzhabekova, Alison W. Tisdale, Efrosini Kokkoli, and Gurumurthy Ramachandran
    Journal of Law, Medicine and Ethics 37 (4): 688-705. 2009.
    The emergence of nanotechnology, and specifically nanobiotechnology, raises major oversight challenges. In the United States, government, industry, and researchers are debating what oversight approaches are most appropriate. Among the federal agencies already embroiled in discussion of oversight approaches are the Food and Drug Administration , Environmental Protection Agency , Department of Agriculture , Occupational Safety and Health Administration , and National Institutes of Health . All can…Read more
  •  7
    Global Challenges
    In Jan Kyrre Berg Olsen Friis, Stig Andur Pedersen & Vincent F. Hendricks (eds.), A Companion to the Philosophy of Technology, Wiley-blackwell. 2012.
    This chapter contains sections titled: Cases of S&T Applied to the MDGs Ways Forward References and Further Reading.
  •  28
    Corporate social responsibility for nanotechnology oversight
    with Aliya Kuzhabekova
    Medicine, Health Care and Philosophy 14 (4): 407-419. 2011.
    Growing public concern and uncertainties surrounding emerging technologies suggest the need for socially-responsible behavior of companies in the development and implementation of oversight systems for them. In this paper, we argue that corporate social responsibility (CSR) is an important aspect of nanotechnology oversight given the role of trust in shaping public attitudes about nanotechnology and the lack of data about the health and environmental risks of nanoproducts. We argue that CSR is s…Read more
  •  79
    Ethics of risk analysis and regulatory review: From bio- to nanotechnology (review)
    with John C. Besley
    NanoEthics 2 (2): 149-162. 2008.
    Risk analysis and regulatory systems are usually evaluated according to utilitarian frameworks, as they are viewed to operate “objectively” by considering the health, environmental, and economic impacts of technological applications. Yet, the estimation of impacts during risk analysis and the decisions in regulatory review are affected by value choices of actors and stakeholders; attention to principles such as autonomy, justice, and integrity; and power relationships. In this article, case stud…Read more
  •  11
    Biotechnology
    In Jan Kyrre Berg Olsen Friis, Stig Andur Pedersen & Vincent F. Hendricks (eds.), A Companion to the Philosophy of Technology, Wiley-blackwell. 2012.
    This chapter contains sections titled: Decision‐making about New Technologies Case Studies for Biotechnology Guidance from the Public References and Further Reading.
  •  24
    Evaluating Oversight Systems for Emerging Technologies: A Case Study of Genetically Engineered Organisms
    with Pouya Najmaie and Joel Larson
    Journal of Law, Medicine and Ethics 37 (4): 546-586. 2009.
    U.S. approaches to oversight of research and technological products have developed over time in an effort to ensure safety to humans, animals, and the environment and to control use in a social context. In modern times, regulatory and oversight tools have evolved to include diverse approaches such as performance standards, tradable allowances, consultations between government and industry, and pre-market safety and efficacy reviews. The decision whether to impose an oversight system, the oversig…Read more
  •  87
    Allhoff, Fritz, Patrick Lin, and Daniel Moore. 2010. What is nanotechnology and why does it matter? From science to ethics Content Type Journal Article Pages 209-211 DOI 10.1007/s11673-011-9289-z Authors Jennifer Kuzma, University of Minnesota, Humphrey School of Public Affairs, 301 19th Ave So, Minneapolis, MN 55455, USA Journal Journal of Bioethical Inquiry Online ISSN 1872-4353 Print ISSN 1176-7529 Journal Volume Volume 8 Journal Issue Volume 8, Number 2